reproductive

REPRODUCTIVE HEALTH

Group 227

BGI VISTA™ Carrier Screening

Most people do not know they are a carrier for an inherited genetic disease until they have a child with the disease. The Vista™ Carrier Screening detects 15,000 mutations across 547 genes, for 626 autosomal-recessive and X-linked genetic disorders.

BGI VISTA™ Carrier Screening can be ordered before or during pregnancy and is ideally suited for couples who want to learn about their genetic status, so that they can make more informed reproductive decisions.

 

BGI VISTA™ Carrier Screening covers most common disease such as:

  • Duchenne Muscular Dystrophy – the most common form of muscular dystrophy affecting children
  • Wilson disease – Worldwide 1 in 30,000 people have Wilson disease
  • Cystic fibrosis – one of the most common deadly inherited disorder among Caucasians
  • Spinal Muscular Atrophy – 1 in 50 people found to be a carrier of this disease
  • Glycogen Storage Disease – The most comprehensive coverage for all types of pomp disease in the market
Group 228

BGI VISTA™ Chromosome Sequencing

BGI VISTA™ Chromosome Sequencing uses NGS based low coverage whole genome sequencing (WGS) to help detect chromosome abnormalities before or during pregnancy. Testing can be performed on a variety of different sample types.


BGI VISTA™ Chromosome Sequencing is especially suitable for:

  • Individuals or couples who have suffered from repeated miscarriage or who have had a child who suffers from a genetic condition
  • Individuals or couples who have had abnormal ultrasonography results, but with negative CGH, SNP results
  • Anyone suspected of chromosome abnormality populations or patients who want to understand if a chromosome abnormality was a factor in a miscarriage
Group 229

BGI VISTA PGS/PGD

Preimplantation genetic screening (PGS) evaluates embryos for extra or missing chromosomes. PGS is an option for any in vitro fertilization (IVF) patient.

BGI VISTA™ PGS is used in conjunction with an IVF cycle. Embryos remain on-site at the patient’s IVF center. Cells are removed from an embryo and sent to BGI for genetic analysis.

BGI VISTA™ PGS can improve the chance of a successful pregnancy while reducing the chance of miscarriage or of havinga child with a chromosome condition.